Rédouane Bettahar

Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial

Abdenour Nabid, Nathalie Carrier, André‐Guy Martin et al. · European Urology · 2018 · 208 citations

Medicine, Oncology, Urology +15

The use of a specific hypofractionated radiation therapy reg imen versus classical fractionation in the treatment of breast cancer: A randomized study of 230 patients

F Baillet, M. Housset, C Maylin et al. · International Journal of Radiation Oncology*Biology*Physics · 1990 · 94 citations

Medicine, Oncology, Radiation Oncology +17

Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A randomised phase III trial

Abdenour Nabid, Nathalie Carrier, Éric Vigneault et al. · European Journal of Cancer · 2020 · 54 citations

Medicine, Oncology, Urology +16

Hypofractionated, Dose Escalation Radiation Therapy for High-Risk Prostate Cancer: The Safety Analysis of the Prostate Cancer Study-5, a Groupe de Radio-Oncologie Génito-Urinaire de Quebec Led Phase 3 Trial

Tamim Niazi, Abdenour Nabid, Talía Malagón et al. · International Journal of Radiation Oncology*Biology*Physics · 2023 · 18 citations

Medicine, Oncology, Radiation Oncology +17

Testosterone recovery after androgen deprivation therapy in localised prostate cancer: Long-term data from two randomised trials

Abdenour Nabid, Nathalie Carrier, Éric Vigneault et al. · Radiotherapy and Oncology · 2024 · 16 citations

Medicine, Oncology, Urology +15